3-Fluoro-N-(furan-2-ylmethyl)aniline, 95%, 250mg

Silver(I) acetate, 99.0%, 1g

2-Methyl-6-(trifluoromethyl)nicotinohydrazide, 95.0%, 5g

1-[(2,5-difluorophenyl)methyl]-1H-pyrazol-3-amine, 95.0%, 2g

(3aS,3a'S,8aR,8a'R)-2,2'-(Cyclopropane-1,1-diyl)bis(8,8a-dihydro-3aH-indeno[1,2-d]oxazole), 98.0%, 5g

(4-iso-Propoxy-benzenesulfonyl)-acetonitrile, 98.0%, 1g

GC capillary column ROTI®Cap-1, 60 m, 0.32 mm, 0.50 µm, 1 Piece(s)

1-PYRIDIN-2-YL-PIPERIDINE-4-CARBOXYLIC ACID HCL, 95.0%, 250mg

C-(6-Chloro-pyridazin-3-yl)-methylamine, 95.0%, 250mg

2-Phenoxyethyl Acetate>99.0%(GC)25g

4-Iodo-2-methylbenzonitrile, 97%, 5g

1-(2-hydroxyethyl)-3,4-dimethylpyrano[2,3-c]pyrazol-6(1H)-one, 95.0%, 1g

3-Bromo-1-methyl-1H-pyrazole-4-carbaldehyde, 98%, 250mg